221 related articles for article (PubMed ID: 34273255)
1. Estimating fetal exposure to the P-gp substrates, corticosteroids, by PBPK modeling to inform prevention of neonatal respiratory distress syndrome.
Anoshchenko O; Milad MA; Unadkat JD
CPT Pharmacometrics Syst Pharmacol; 2021 Sep; 10(9):1057-1070. PubMed ID: 34273255
[TBL] [Abstract][Full Text] [Related]
2. Optimization of the betamethasone and dexamethasone dosing regimen during pregnancy: a combined placenta perfusion and pregnancy physiologically based pharmacokinetic modeling approach.
Van Der Heijden JEM; Van Hove H; Van Elst NM; Van Den Broek P; Van Drongelen J; Scheepers HCJ; De Wildt SN; Greupink R
Am J Obstet Gynecol; 2024 May; ():. PubMed ID: 38763343
[TBL] [Abstract][Full Text] [Related]
3. Successful Prediction of Human Fetal Exposure to P-Glycoprotein Substrate Drugs Using the Proteomics-Informed Relative Expression Factor Approach and PBPK Modeling and Simulation.
Anoshchenko O; Storelli F; Unadkat JD
Drug Metab Dispos; 2021 Oct; 49(10):919-928. PubMed ID: 34426410
[TBL] [Abstract][Full Text] [Related]
4. Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model II: Verification of the model for passive placental permeability drugs.
Zhang Z; Unadkat JD
Drug Metab Dispos; 2017 Aug; 45(8):939-946. PubMed ID: 28049636
[TBL] [Abstract][Full Text] [Related]
5. Estimation of Fetal-to-Maternal Unbound Steady-State Plasma Concentration Ratio of P-Glycoprotein and/or Breast Cancer Resistance Protein Substrate Drugs Using a Maternal-Fetal Physiologically Based Pharmacokinetic Model.
Peng J; Ladumor MK; Unadkat JD
Drug Metab Dispos; 2022 May; 50(5):613-623. PubMed ID: 35149540
[TBL] [Abstract][Full Text] [Related]
6. Maternal Betamethasone for Prevention of Respiratory Distress Syndrome in Neonates: Population Pharmacokinetic and Pharmacodynamic Approach.
Foissac F; Zheng Y; Hirt D; Lui G; Bouazza N; Ville Y; Goffinet F; Rozenberg P; Kayem G; Mandelbrot L; Benaboud S; Jarreau PH; Tréluyer JM
Clin Pharmacol Ther; 2020 Nov; 108(5):1026-1035. PubMed ID: 32394434
[TBL] [Abstract][Full Text] [Related]
7. Predicting Human Fetal Drug Exposure Through Maternal-Fetal PBPK Modeling and In Vitro or Ex Vivo Studies.
Balhara A; Kumar AR; Unadkat JD
J Clin Pharmacol; 2022 Sep; 62 Suppl 1(Suppl 1):S94-S114. PubMed ID: 36106781
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of antenatal steroid therapy is dependent on the duration of low-concentration fetal exposure: evidence from a sheep model of pregnancy.
Kemp MW; Saito M; Usuda H; Watanabe S; Sato S; Hanita T; Kumagai Y; Molloy TJ; Clarke M; Eddershaw PJ; Musk GC; Schmidt A; Ireland D; Furfaro L; Payne MS; Newnham JP; Jobe AH
Am J Obstet Gynecol; 2018 Sep; 219(3):301.e1-301.e16. PubMed ID: 29758177
[TBL] [Abstract][Full Text] [Related]
9. Area/moment and compartmental modeling of pharmacokinetics during pregnancy: applications to maternal/fetal exposures to corticosteroids in sheep and rats.
Samtani MN; Schwab M; Nathanielsz PW; Jusko WJ
Pharm Res; 2004 Dec; 21(12):2279-92. PubMed ID: 15648260
[TBL] [Abstract][Full Text] [Related]
10. Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model I: Insights into Factors that Determine Fetal Drug Exposure through Simulations and Sensitivity Analyses.
Zhang Z; Imperial MZ; Patilea-Vrana GI; Wedagedera J; Gaohua L; Unadkat JD
Drug Metab Dispos; 2017 Aug; 45(8):920-938. PubMed ID: 28588050
[TBL] [Abstract][Full Text] [Related]
11. Oral antenatal corticosteroids evaluated in fetal sheep.
Schmidt AF; Jobe AH; Kannan PS; Bridges JP; Newnham JP; Saito M; Usuda H; Kumagai Y; Fee EL; Clarke M; Kemp MW
Pediatr Res; 2019 Nov; 86(5):589-594. PubMed ID: 31365919
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Maternal Drug Exposure Following the Administration of Antenatal Corticosteroids During Late Pregnancy Using Physiologically-Based Pharmacokinetic Modeling.
Ke AB; Milad MA
Clin Pharmacol Ther; 2019 Jul; 106(1):164-173. PubMed ID: 30924921
[TBL] [Abstract][Full Text] [Related]
13. Oral dosing for antenatal corticosteroids in the Rhesus macaque.
Schmidt AF; Kemp MW; Milad M; Miller LA; Bridges JP; Clarke MW; Kannan PS; Jobe AH
PLoS One; 2019; 14(9):e0222817. PubMed ID: 31536601
[TBL] [Abstract][Full Text] [Related]
14. Minimal physiologically-based hybrid model of pharmacokinetics in pregnant women: Application to antenatal corticosteroids.
Krzyzanski W; Milad MA; Jobe AH; Jusko WJ
CPT Pharmacometrics Syst Pharmacol; 2023 May; 12(5):668-680. PubMed ID: 36917704
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Maternal and Fetoplacental Concentrations of Cefazolin, Cefuroxime, and Amoxicillin during Pregnancy Using Bottom-Up Physiologically Based Pharmacokinetic Models.
Abduljalil K; Ning J; Pansari A; Pan X; Jamei M
Drug Metab Dispos; 2022 Apr; 50(4):386-400. PubMed ID: 35046066
[TBL] [Abstract][Full Text] [Related]
16. Variability in the efficacy of a standardized antenatal steroid treatment was independent of maternal or fetal plasma drug levels: evidence from a sheep model of pregnancy.
Takahashi T; Saito M; Schmidt AF; Usuda H; Takahashi Y; Watanabe S; Hanita T; Sato S; Kumagai Y; Koshinami S; Ikeda H; Carter S; Clarke M; Fee EL; Yaegashi N; Newnham JP; Jobe AH; Kemp MW
Am J Obstet Gynecol; 2020 Dec; 223(6):921.e1-921.e10. PubMed ID: 32445634
[TBL] [Abstract][Full Text] [Related]
17. Prediction of Maternal and Fetal Acyclovir, Emtricitabine, Lamivudine, and Metformin Concentrations during Pregnancy Using a Physiologically Based Pharmacokinetic Modeling Approach.
Abduljalil K; Pansari A; Ning J; Jamei M
Clin Pharmacokinet; 2022 May; 61(5):725-748. PubMed ID: 35067869
[TBL] [Abstract][Full Text] [Related]
18. Adaptations in placental phenotype depend on route and timing of maternal dexamethasone administration in mice.
Vaughan OR; Sferruzzi-Perri AN; Coan PM; Fowden AL
Biol Reprod; 2013 Oct; 89(4):80. PubMed ID: 23986571
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Various Approaches to Estimate Transplacental Clearance of Vancomycin for Predicting Fetal Concentrations using a Maternal-Fetal Physiologically Based Pharmacokinetic Model.
Yan Y; Wang Q; Wu W; Yi H; Xie F
Pharm Res; 2024 May; 41(5):899-910. PubMed ID: 38684563
[TBL] [Abstract][Full Text] [Related]
20. Successful Prediction of Fetal Exposure to Dual BCRP/P-gp Drug Substrates Using the Efflux Ratio-Relative Expression Factor Approach and PBPK M&S.
Balhara A; Yin M; Unadkat JD
Clin Pharmacol Ther; 2024 May; 115(5):1044-1053. PubMed ID: 38124355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
